4//SEC Filing
RICHMOND TIMOTHY J. 4
Accession 0001415889-25-006024
CIK 0001551152other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 5:00 PM ET
Size
19.4 KB
Accession
0001415889-25-006024
Insider Transaction Report
Form 4
AbbVie Inc.ABBV
RICHMOND TIMOTHY J.
SVP, Human Resources
Transactions
- Sale
Common stock, $0.01 par value
2025-02-26$202.92/sh−13,073$2,652,773→ 49,113 total - Sale
Common stock, $0.01 par value
2025-02-26$202.06/sh−1,400$282,884→ 50,591 total - Sale
Common stock, $0.01 par value
2025-02-26$203.64/sh−1,526$310,755→ 44,284 total - Sale
Common stock, $0.01 par value
2025-02-26$203.63/sh−4,829$983,329→ 44,284 total - Sale
Common stock, $0.01 par value
2025-02-26$202.93/sh−4,781$970,208→ 45,810 total - Exercise/Conversion
Common stock, $0.01 par value
2025-02-26$114.36/sh+22,210$2,539,936→ 66,494 total - Sale
Common stock, $0.01 par value
2025-02-26$201.97/sh−4,308$870,087→ 62,186 total - Exercise/Conversion
Option (Right to buy)
2025-02-26$114.36/sh−22,210$2,539,936→ 0 totalExercise: $114.36From: 2019-02-15Exp: 2028-02-14→ Common Stock (22,210 underlying)
Footnotes (8)
- [F1]This sale was executed pursuant to a Rule 10b5-1 plan that was entered into by the Reporting Person on November 27, 2024.
- [F2]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $201.58 to $202.45, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $202.58 to $203.56, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $203.58 to $203.65, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $201.55 to $202.48, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F6]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $202.55 to $203.46, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F7]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $203.55 to $203.68, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F8]Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.
Documents
Issuer
AbbVie Inc.
CIK 0001551152
Entity typeother
Related Parties
1- filerCIK 0001563523
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 5:00 PM ET
- Size
- 19.4 KB